Strategies for discontinuing long-term benzodiazepine use: meta-analysis

Br J Psychiatry. 2006 Sep:189:213-20. doi: 10.1192/bjp.189.3.213.

Abstract

Background: The prevalence of benzodiazepine consumption in European countries remains at 2-3% of the general population despite the well-documented disadvantages of long-term use.

Aims: To review systematically the success rates of different benzodiazepine discontinuation strategies.

Method: Meta-analysis of comparable intervention studies.

Results: Twenty-nine articles met inclusion criteria. Two groups of interventions were identified; minimal intervention (e.g. giving simple advice in the form of a letter or meeting to a large group of people; n=3), and systematic discontinuation (defined as treatment programmes led by a physician or psychologist; n=26). Both were found to be significantly more effective than treatment as usual: minimal interventions (pooled OR=2.8, 95% CI 1.6-5.1); systematic discontinuation alone (one study, OR=6.1, 95% CI 2.0-18.6). Augmentation of systematic discontinuation with imipramine (two studies, OR=3.1, 95% CI 1.1-9.4) or group cognitive-behavioural therapy for patients with insomnia (two studies, OR=5.5, 95% CI 2.3-14.2) was superior to systematic discontinuation alone.

Conclusions: Evidence was found for the efficacy of stepped care (minimal intervention followed by systematic discontinuation alone) in discontinuing long-term benzodiazepine use.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Anti-Anxiety Agents / administration & dosage
  • Anti-Anxiety Agents / adverse effects*
  • Benzodiazepines / administration & dosage
  • Benzodiazepines / adverse effects*
  • Female
  • Humans
  • Male
  • Randomized Controlled Trials as Topic
  • Substance Withdrawal Syndrome / prevention & control*

Substances

  • Anti-Anxiety Agents
  • Benzodiazepines